Indoco Remedies Announces Board Meeting to Approve Q1 Financial Results and Updates Trading Window Closure Period
Indoco Remedies Ltd has scheduled a Board of Directors meeting to consider and approve the Unaudited Standalone and Consolidated Financial Results for the Quarter Ended June 30, 2026. The company also provided an update regarding the closure of the trading window for its equity shares.The Board meeting is set to take place on Tuesday, July 28, 2026. During this session, the board will review and approve the financial results pertaining to the quarter ended June 30, 2026.
In addition to the board agenda, Indoco Remedies confirmed the status of the trading window for its Designated Persons and their immediate relatives. The trading window shall remain closed until July 30, 2026. This closure period extends 48 hours following the declaration of the Unaudited Standalone and Consolidated Financial Results for the Quarter Ended June 30, 2026.
INDOCO Stock Price Movement
As of 1:22 PM, shares of Indoco Remedies Limited are edging higher to ₹251, gaining 0.99% in live trading today. The stock is currently seeing robust interest, as over 71,415 shares have been traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.